ArticleMolecular and clinical oncology2025

Drug-induced interstitial lung disease caused by gefitinib in the treatment of non-small cell lung cancer: A case report.

Jing Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.